(166) delves into the potential therapeutic implications of acetate in cancer treatment, focusing on its impact on the expression of the poliovirus receptor (PVR/CD155), an immunological checkpoint ligand in colon cancer cells. This evidence concerns the gene PVR and colonic neoplasm.